Your ANSwer for Workers' Compensation Medical Cost Containment

Call Us Today!|info@ans-solutions.com

National WC & Disability Conference December 6-8, 2017

Visit ANS Solutions in Booth 2615
National WC & Disability Conference
December 6-8, 2017
Mandalay Bay – Las Vegas, NV

By |April 28th, 2017|ANS News & Events|Comments Off on National WC & Disability Conference December 6-8, 2017

The Impact of Workers’ Compensation Compounding

As custom-made compound prescriptions concoctions continue to rack-up higher workers’ compensation costs, insurers are scrambling to find alternatives and employers are looking for relief from equally inflated premiums. With little to no evidence as to the efficacy of such creations, many states have implemented treatment guidelines directing doctors to more evidentiary-based, easily reimbursable options. Despite guidelines and formularies however, loopholes in coverage continue to allow providers to sell millions of dollars of compounds, with many companies submitting inflated reimbursement bills in their attempts to get paid.

A Growing Issue in […]

By |December 15th, 2016|Drug Utilization Review, Workers Compensation Industry|Comments Off on The Impact of Workers’ Compensation Compounding
  • Permalink Gallery

    New FDA Warning: Avoid Prescribing Opioids & Benzos Together

New FDA Warning: Avoid Prescribing Opioids & Benzos Together

In a recent announcement by the FDA, boxed warning labels will now be required to advise against the utilization of prescription opioid pain medicines alongside benzodiazepines unless no other adequate alternative treatment method exists. Warnings about the risks of combining these two classes of drugs are nothing new. Already required on drug warning labels, additional black box warnings are an effort by the FDA to reach out to those who may have “missed the message.”

Classified as Central Nervous System (CNS) depressants, each drug alone can trigger side effects such […]

By |November 21st, 2016|Pharmaceutical Industry, Pharmacotherapy Review|Comments Off on New FDA Warning: Avoid Prescribing Opioids & Benzos Together
  • pharmacotherapy review ANS Solutions
    Permalink Gallery

    Prescription Drugs and the Workers’ Compensation Cost Containment Arena

Prescription Drugs and the Workers’ Compensation Cost Containment Arena

The U.S. remains the biggest global consumer of prescription drugs, up from around 76 million in 1991 to nearly 207 million in 2013 however a recent court ruling has called into direct question the prescription practices of physicians nationwide (Volkow).

The occurrence of unnecessary or medically inappropriate prescribing of opioids in pain management is compromising the lives and well-being of injured workers.  There are a number of serious issues concerning the use of opioids in pain management:

  • Not cost effective
    Evidence-based reviews are seldom consulted prior to the prescribing of opioids, and […]

By |November 7th, 2016|Pharmacotherapy Review, Workers Compensation Payers|Comments Off on Prescription Drugs and the Workers’ Compensation Cost Containment Arena

What’s Trending with California Workers’ Compensation

Though workers’ comp claims frequency is declining, a recently released California hospital report indicates claim severity is on the rise. Obtaining data from 35 hospitals and individual facilities, the Milliman and Keenan Healthcare report sourced more than 3,500 claims for review.

Trends identified in the report:

  • A decline in indemnity and medical-only claims, with ALAE costs playing an increasing role in overall claims costs in recent years. More specifically:
    • Higher average costs per indemnity for workers over 30.
    • Lesser average severity of indemnity claims in workers 30 and younger, with payments more likely […]
By |October 28th, 2016|Pharmacotherapy Review, Workers Compensation Payers|Comments Off on What’s Trending with California Workers’ Compensation

Why ANS Pharmacotherapy Review is so Effective

The prescription pain medication crisis is taking its toll across the U.S. Costs are extreme, with a broad array of collateral damage fanning out from those effected to families and industries, among the hardest hit, workman’s comp. So extreme are the effects of addictive and deadly prescription opioids, even the Federal Government has taken notice, with the CDC stepping in to release new opioid prescribing best practices earlier this year in hopes of ushering in a new era for an ailing nation. The issue is out in the open. […]

By |October 17th, 2016|Drug Utilization Review, Pharmacotherapy Review|Comments Off on Why ANS Pharmacotherapy Review is so Effective

Bipartisan Opioid Abuse Bill

In an effort to reverse the rapidly rising death toll from heroin, prescription drugs, and opioids across the U.S. which has recently risen to surpass automobile accidents as the leading cause of injury-related deaths according to the CDC, legislation has been drafted in a rare bipartisan effort.

The Comprehensive Addiction and Recovery Act (CARA)
Designed to strengthen prescription drug monitoring programs, better trace the diversion of opioid drugs, and increase promotion and access to addiction recovery services, CARA will also open up a variety of prevention and treatment avenues:

  • Prevention and […]
By |September 26th, 2016|Drug Utilization Review, Pharmacotherapy Review|Comments Off on Bipartisan Opioid Abuse Bill

Patient Engagement and Prescription Drug Label Enhancements

Upcoming improvements to prescription drug labeling are hoped to positively affect patient care across the board. Intentionally kept in the dark on the ingredients and indications of prescription drugs for well-over 100 years, the healthcare industry is shifting from the past’s blind trust to finally realizing today’s modern paradigm: Engaging patients as active participants in their own healthcare endeavors.

Small Label, Big Impact
Improving the synchronization between in-office care and home care, the FDA’s latest labeling procedures will not only help patients under a physician’s care better understand why each medication […]

By |September 12th, 2016|Drug Utilization Review, Pharmacotherapy Review|Comments Off on Patient Engagement and Prescription Drug Label Enhancements

Is Regulation the Answer to Rising Pharma Costs?

National pressure has been building for government regulation on pharmaceutical costs.  A recent poll from the Kaiser Family Foundation found that 72% of Americans think drug costs are unreasonable and demand more transparency from drug companies, especially when it comes to how they set prices.(1) In the face of this discourse, the accountability of pharmaceutical companies has grown as a key focus of recent state and federal regulations.

In the state of Vermont, expensive prescriptions drugs distributed by manufacturers must now justify their exorbitant costs, according to a newly […]

By |August 30th, 2016|Medical Cost Containment, Pharmaceutical Cost Containment, Workers Compensation Payers|Comments Off on Is Regulation the Answer to Rising Pharma Costs?
  • Pharmacotherapy Review Medical Cost Containment Strategy
    Permalink Gallery

    The Importance of a Multifaceted Approach to Medical Cost Containment

The Importance of a Multifaceted Approach to Medical Cost Containment

The biggest hurdle in workers’ compensation medical cost containment is that the injured worker is not getting better. Even though WC claims have steadily declined over the last decade, medical costs keep rising as do the sub-par outcomes for the patient and the payer. What we are seeing is that the inter-connectivity of many factors is hindering the end goal of optimized outcomes. A multidimensional approach is crucial not only for combatting pharma costs, but also for ensuring optimal outcomes for injured workers.

At the end of the […]

By |August 15th, 2016|Medical Cost Containment, Pharmacotherapy Review, Workers Compensation Payers|Comments Off on The Importance of a Multifaceted Approach to Medical Cost Containment